http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-212139-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6fbd0ac6f8b381ef42f7d1a6eed1dba |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35 |
| filingDate | 2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e2e982a10d154ecfa750fe21d117383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_331ddc1d5a27fffba3284beb33cb1676 |
| publicationDate | 2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PL-212139-B1 |
| titleOfInvention | Recombinant allergen, use of a recombinant allergen, composition containing two or more variants of recombinant mutant allergens, use of such composition, pharmaceutical composition containing the recombinant allergen or said composition, use of the recombinant allergen, composition or pharmaceutical composition, method of preparing the pharmaceutical composition, method of preparing the recombinant allergen, method preparing a recombinant allergen library, DNA sequence encoding the recombinant allergen, an expression vector comprising said DNA, a host cell containing such an expression vector, a method for producing a recombinant allergen mutant, and a diagnostic assay to assess the suitability, safety or outcome of therapy |
| abstract | Novel recombinant allergens with multiple mutations and reduced IgE binding affinity are disclosed. The allergens are mutants of naturally occurring allergens. The overall alpha-carbon backbone tertiary structure is essentially preserved. Also disclosed is a method for preparing such recombinant allergens as well as uses thereof. |
| priorityDate | 2002-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 241.